annual cash & cash equivalents:
$143.43M-$122.03M(-45.97%)Summary
- As of today (June 29, 2025), IBRX annual cash & cash equivalents is $143.43 million, with the most recent change of -$122.03 million (-45.97%) on December 31, 2024.
- During the last 3 years, IBRX annual cash & cash equivalents has fallen by -$37.67 million (-20.80%).
- IBRX annual cash & cash equivalents is now -45.97% below its all-time high of $265.45 million, reached on December 31, 2023.
Performance
IBRX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$60.66M-$82.77M(-57.71%)Summary
- As of today (June 29, 2025), IBRX quarterly cash & cash equivalents is $60.66 million, with the most recent change of -$82.77 million (-57.71%) on March 31, 2025.
- Over the past year, IBRX quarterly cash & cash equivalents has dropped by -$72.38 million (-54.40%).
- IBRX quarterly cash & cash equivalents is now -77.15% below its all-time high of $265.45 million, reached on December 31, 2023.
Performance
IBRX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IBRX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.0% | -54.4% |
| 3 y3 years | -20.8% | +66.7% |
| 5 y5 years | - | - |
IBRX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.0% | +37.1% | -77.2% | +66.7% |
| 5 y | 5-year | -46.0% | +310.8% | -77.2% | +73.7% |
| alltime | all time | -46.0% | +310.8% | -77.2% | +73.7% |
IBRX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $60.66M(-57.7%) |
| Dec 2024 | $143.43M(-46.0%) | $143.43M(+28.1%) |
| Sep 2024 | - | $111.97M(-13.9%) |
| Jun 2024 | - | $130.10M(-2.2%) |
| Mar 2024 | - | $133.03M(-49.9%) |
| Dec 2023 | $265.45M(+153.7%) | $265.45M(+49.2%) |
| Sep 2023 | - | $177.96M(+309.1%) |
| Jun 2023 | - | $43.51M(-50.8%) |
| Mar 2023 | - | $88.48M(-15.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $104.64M(-42.2%) | $104.64M(+0.5%) |
| Sep 2022 | - | $104.16M(+68.3%) |
| Jun 2022 | - | $61.90M(+70.1%) |
| Mar 2022 | - | $36.38M(-79.9%) |
| Dec 2021 | $181.10M(+418.7%) | $181.10M(+180.7%) |
| Sep 2021 | - | $64.52M(-23.1%) |
| Jun 2021 | - | $83.96M(+87.9%) |
| Mar 2021 | - | $44.68M(+28.0%) |
| Dec 2020 | $34.91M | $34.91M |
FAQ
- What is ImmunityBio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ImmunityBio?
- What is ImmunityBio annual cash & cash equivalents year-on-year change?
- What is ImmunityBio quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for ImmunityBio?
- What is ImmunityBio quarterly cash & cash equivalents year-on-year change?
What is ImmunityBio annual cash & cash equivalents?
The current annual cash & cash equivalents of IBRX is $143.43M
What is the all time high annual cash & cash equivalents for ImmunityBio?
ImmunityBio all-time high annual cash & cash equivalents is $265.45M
What is ImmunityBio annual cash & cash equivalents year-on-year change?
Over the past year, IBRX annual cash & cash equivalents has changed by -$122.03M (-45.97%)
What is ImmunityBio quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of IBRX is $60.66M
What is the all time high quarterly cash & cash equivalents for ImmunityBio?
ImmunityBio all-time high quarterly cash & cash equivalents is $265.45M
What is ImmunityBio quarterly cash & cash equivalents year-on-year change?
Over the past year, IBRX quarterly cash & cash equivalents has changed by -$72.38M (-54.40%)